#COVID-19 vaccine

The J&J vaccine, which is easier to store and deliver, will help speed up the coronavirus vaccine rollout.

People living with cancer are at higher risk for severe illness and death due to COVID-19.

NIAID director Anthony Fauci, MD, and coauthors emphasize the need for a global response to COVID-19.

Certain racial/ethnic groups and older people aren’t being adequately represented and trial reporting guidelines aren’t being followed.

In this Q&A, Dr. Pergam discusses some of the questions people with cancer and cancer survivors have about COVID-19 vaccines.

Among Native Americans, the COVID-19 vaccine rollout so far has been a success story.

If you’re wondering how the hell I had a surprise PSA test and didn’t I feel the needle going into my arm, yes, I did. Let me explain.

In most places, elderly people are pitted against one another, competing on an unstable technological playing field for limited shots.

Public health authorities are relying on community health workers to be a bridge to communities that have been hardest hit by COVID-19.

The question of how and when to get kids back into classrooms often depends less on science than politics.

The public can watch the proceedings on the FDA website and the agency’s YouTube, Facebook and Twitter channels.

The coronavirus vaccines are safe and should be effective even for people with advanced cancer.

Forcing companies to gear up production won’t provide much-needed doses anytime soon.

Another vaccine, from Novavax, was 89% effective in a U.K. trial, but both were less potent against the South African coronavirus mutation.

In some cases, anti-vaccine activists are fabricating stories of deaths that never occurred.

A slow vaccine rollout and the emergence of new coronavirus mutations threaten progress in reducing new cases and death.